
Pharmaceuticals, Год журнала: 2025, Номер 18(3), С. 391 - 391
Опубликована: Март 10, 2025
Background: The low solubility and poor skin permeability of sulfasalazine (SLZ) present significant challenges for its effective topical delivery. objective the current investigation is to formulate a hydrogel-based SLZ-loaded cyclodextrin nanosponge therapy in psoriasis. Methods: nanosponges were prepared by melt polymerization method evaluated physiochemical characteristics, drug release, cytocompatibility. selected (SLZ-NS4) transformed hydrogel further rheology, texture, safety, permeability, vivo anti-psoriatic effect mouse tail imiquimod-induced psoriasis-like inflammation models mice. Results: Physiochemical data confirms nanoscale architecture, inclusion nanosponges, crystalline structure, formulation stability. release profile SLZ-NS4 revealed sustained behavior (22.98 ± 2.24% 3 h). Cytotoxicity assays indicated negligible toxicity against THP1 cells, resulting higher viability cells than pure SLZ (p < 0.05). HET-CAM assay confirmed while confocal laser scanning microscopy demonstrated deeper permeation SLZ. In model, remarkable decline relative epidermal thickness, potential improvement percent orthokeratosis, activity with respect control was observed animals treated hydrogel. efficiency developed SLZ-NS4-loaded treating psoriasis PASI score (81.68 3.61 84.86 5.74 1 2% w/v SLZ-NS-HG). Histopathological analysis assessment oxidative stress markers profound fabricated Conclusions: These findings highlight delivery system as an
Язык: Английский